Report overview
An orphan drug is a pharmaceutical agent developed to treat medical conditions which, because they are so rare, would not be profitable to produce without government assistance. The conditions are referred to as orphan diseases.
This report contains market size and forecasts of Orphan Drugs in Global, including the following market information:
Global Orphan Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Orphan Drugs market was valued at 143200 million in 2021 and is projected to reach US$ 269190 million by 2028, at a CAGR of 9.4% during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oncology Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Orphan Drugs include Bristol-Myers Squibb, Roche, Novartis, Johnson & Johnson, Pfizer, Amgen, Sanofi, AstraZeneca and Takeda, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Orphan Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Orphan Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Orphan Drugs Market Segment Percentages, by Type, 2021 (%)
Oncology
Pulmonary
Neurology
Hematology
Endocrinology
Cardio-vascular
Metabolic Disorders
Others
Global Orphan Drugs Market, by End Users, 2017-2022, 2023-2028 ($ millions)
Global Orphan Drugs Market Segment Percentages, by End Users, 2021 (%)
Baby and Child
Teenager
Adult
Other
Global Orphan Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Orphan Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Orphan Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Orphan Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bristol-Myers Squibb
Roche
Novartis
Johnson & Johnson
Pfizer
Amgen
Sanofi
AstraZeneca
Takeda
Vertex Pharmaceuticals
AbbVie
Biogen
Eli Lilly
